120 - Once-Weekly Semaglutide Provides Better Value for Money Than a Broad Range of Other Type 2 Diabetes Treatments in Canada: A Relative Cost of Control Analysis

Publication date: October 2018Source: Canadian Journal of Diabetes, Volume 42, Issue 5, SupplementAuthor(s): Aiden Ranke Liu, Peter Galthen Bech, Lawrence A. Leiter, Søren Ilsøe Moreno, Jonas Håkan-Bloch, Pierre Johansen
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research